Skip to Content

The EGFR-Tyrosine Kinase Inhibitors (EGFR-TKIs) and Immune Checkpoint Inhibitors (ICIs) for Non-Small Cell Lung Cancer

This special issue belongs to the section "Cancer Therapy".

Special Issue Information

Keywords

  • non-small cell lung cancer
  • target therapy
  • EGFR-tyrosine kinase inhibitors
  • immunotherapy
  • immune checkpoint inhibitors
  • molecular analysis
  • surgery
  • precision medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Published Papers

XFacebookLinkedIn
Cancers - ISSN 2072-6694